Rhumatological manifestations of psoriasis;Psoriasis: Manifestations rhumatologiques

Presse Medicale

Volumn 28, Issue 23, 1999, Pages 1251-1258

  Grasland, A ^a   Vinceneux, P ^a  

^a HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AURANOFIN; AZARIBINE; AZATHIOPRINE; BROMOCRIPTINE; CLADRIBINE; COLCHICINE; CYCLOSPORIN; GAMMA INTERFERON; GOLD SALT; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ARTHRITIS; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; JOINT SURGERY; MALE; PATHOGENESIS; PREVALENCE; PSORIASIS; PUSTULAR PSORIASIS; PUVA; RADIOGRAPHY; REVIEW; RHEUMATIC DISEASE; SPONDYLITIS; TREATMENT INDICATION;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; NAIL DISEASES; PSORIASIS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 0033606475     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Baker H, Golding DN, Thompson M. Psoriasis and arthritis. Ann Intern Med 1963 ; 58:909-25.
2. Avila R, Pugh DG, Slocumb CH, Winkelmann RK. Psoriatic arthritis: a roentgenologic study. Radiology 1960 ; 75:691-701.
3. Wright V. Psoriatic arthritis. A comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis. Ann Rheum Dis 1961 ; 20:123-31.
4. Dryll A, Cazalis P, Debeyre N, de Seze S. Rhumatisme psoriasique. Etude prospective de 50 cas, sans atteinte sacroiliaque et sans facteur rhumatoïde, appariés à 50 cas de polyarthrites rhumatoïdes. Nouv Presse Med 1975 ; 4:1408-12.
5. Roberts ME, Wright V, Hill AGS, Mehra AC. Psoriatic arthritis. Follow up Study. Ann Rheum Dis 1976 ; 35:206-12.
6. Dougados M, Van Der Linden S, Juhlin R et al. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991 ; 34:1218-27.
7. Amor B, Dougados M, Mijiyawa M. Critères de classification des spondylarthropathies. Rev Rhum 1990 ; 57:85-9.
8. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973 ; 3:55-78.
9. O'Neill T, Silman AJ. Historical background and epidemiology. Bailliéres's Clin Rheumatol 1994 ; 8:245-61.
10. Leczinsky CG. The incidence of arthropathy in a ten-year series of psoriasis cases. Acta Dermatol Venereol 1948 ; 28:483-7.
11. Hellgren L. Association between rheumatoid arthritis and psoriasis in total populations. Acta Rheum Scand 1969 ; 15:316-26.
12. Little H, Harvie JN, Lester RS. Psoriatic arthritis in severe psoriasis. Can Med Assoc J 1975 ; 12:317-9.
13. Leonard DG, O'Duffy JD, Rogers RS. Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis. Mayo Clin Proc 1978 ; 53:511-8.
14. Green L, Meyers OL, Gordon W, Briggs B. Arthritis in psoriasis. Ann Rheum Dis 1981 ; 40:366-9.
15. Scarpa R, Oriente P, Pucino A et al. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984 ; 23:246-50.
16. Stern RS. The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 1985 ; 12:315-20.
17. Salvarini C, Lo Scocco G, Macchioni P et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 1995 ; 22:1499-503.
18. Gladman DD. Natural history of psoriatic arthritis. Baillières's Clin Rheumatol 1994 ; 8:379-94.
19. Ryckewaert A, Cazalis P. Rhumatisme psoriasique. Rev Médecine 1980 ; 39:2069-78.
20. Gladman DD. Toward unraleving the mystery of psoriatic arthritis. Arthritis Rheum 1993 ; 36:881-4.
21. Kammer GM, Soter NA, Gibson DJ, Schur PH. Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 1979 ; 9:75-97.
22. Laurent MR. Psoriatic arthritis. Clin Rheum Dis 1985 ; 11:61-85.
23. McHugh NJ, Laurent MR, Treadwell BU, Tweed JM, Dagger J. Psoriatic arthritis: clinical subgroups and histocompatibility antigens. Ann Rheum Dis 1987 ; 46:184-8.
24. Gladman D, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model. Arthritis Rheum 1995 ; 6:845-50.
25. Fournié B, Granel J, Heraud A et al. HLA-B et rhumatisme psoriasique. Etude de 193 cas. Rev Rhum 1991 ; 58:269-73.
26. Espinoza LR, Berman A, Vasey FB, Cahalin C, Nelson R, Germain BF. Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis Rheum 1988 ; 8:1034-40.
27. Langevitz, P, Buskila D, Gladman DD. Psoriatic arthritis precipitated by physical trauma. J Rheumatol 1990 ; 17:695-7.
28. Sandorfi N, Freundlich B. Psoriatic and seronegative inflammatory arthropathy associated with a traumatic onset: 4 cases and a review of the literature. J Rheumatol 1997 ; 24:187-92.
29. Thomachot B, Lafforgue P, Acquaviva PC. Rhumatisme psoriasique post-traumatique. Deux observations. Presse Med 1996 ; 25:21-4.
30. Goupille P, Soutif D, Valat JP. Psoriatic arthritis precipated by physical trauma. J Rheumatol 1991 ; 18:633.
31. Scarpa R, Del Puente A, di Girolamo C, della Valle G, Lubrano E, Oriente P. Interplay between environmental factors, articular invovement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis 1992 ; 51:78-9.
32. Wright V. Psoriatic arthritis. A comparative study of rheumatoid arthritis, psoriasis, and arthritis associated with psoriasis. Arch Derm 1959 ; 80:27-35.
33. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA). An analysis of 220 patients. Q J Med 1987 ; 62:127-41.
34. Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991 ; 30:245-50.
35. Fournié A, Ayrolles Ch, Sellami S, Guyard C, Fournié B. Histoire naturelle du rhumatisme psoriasique. Etude prospective de 82 cas. Rev Rhum 1980 ; 45:309-16.
36. Oriente P, Biondi-Oriente C, Scarpa R. Clinical manifestations. Bailliéres's Clin Rheumatol 1994 ; 8:277-94.
37. Goupille P, Védère V, Roulot B, Brunais J, Valat JP. Incidence of osteoperiostitis of the great toe in psoriatic arthritis. J Rheumatol 1996 ; 23:1553-6.
38. Lambert JR, Wright V. Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis. Q J Med 1977 ; 184:411-25.
39. Salvarani C, Cantini F, Olivieri I et al. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol 1997 ; 24:1106-10.
40. Taylor P, Stoecker W. Enthesitis of the elbow in psoriatic arthritis. J Rheumatol 1997 ; 24:2263-9.
41. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994 ; 33:834-9.
42. Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991 ; 30:339-45.
43. Kahn MF. Why the «SAPHO» syndrome? J Rheumatol 1995 ; 22:2017-9.
44. Kahn MF. Actualité du syndrome SAPHO. Presse Med 1995 ; 24:338-40.
45. Fournié B, Boutes A, Dromer C et al. Etude prospective de l'atteinte du plastron stemo-costo-claviculaire dans la spondylarthrite ankylosante et dans le rhumatisme psoriasique. Rev rhum 1997 ; 64:23-6.
46. Magub M, Sany J. Le rhumatisme psonasique. Sem Hôp Paris 1984 ; 60:205-12.
47. Ahmed Q, Chung-Park M, Mustafa K, Khan MA. Psoriatic spondylarthropathy with secondary amyloidosis. J Rheumatol 1996 ; 23:1107-10.
48. Schatteman L, Mielants H, Veys EM et al. Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. J Rheumatol 1995 ; 22:680-3.
49. Shore A, Ansell BM. Juvenile psoriatic arthritis. An analysis of 60 cases. J Pediatrics 1982 ; 100:529-35.
50. Ansell BM. Juvenile psoriatic arthritis, Baillières's Clin Rheumatol 1994 ; 8:317-32.
51. Southwood TR, Petty RE, Malleson PN et al. Psoriatic arthritis in children. Arthritis Rheum 1989 ; 32:1007-13.
52. Roberton DM, Cabral DA, Malleson PN, Petty RE. Juvenile psoriatic arthritis: followup and evaluation of diagnostic criteria. J Rheumatol 1996 ; 23:166-70.
53. Cazalis P. Le vrai visage du rhumatisme psoriasique. In: de Sèze S, Ryckewaert A, Kahn MF, Lemaire V. L'actualité Rhumatologique présentée au praticien 1975. Ed Expansion scientifique, Paris: 21-8.
54. Porter GG. Plain radiology and other imaging techniques. Baillières's Clin Rheumatol 1994 ; 8:465-81.
55. Resnick D, Niwayama G. Psoriatic arthritis. In: Resnick, Niwayama. Diagnosis of bone and joint disorders 1981. Ed W.B. Saunders Company Philadelphia, London, Toronto: 1103-29.
56. Olievieri I, Barozzi L, Pierro A, De Matteis M, Padula A, Pavlica P. Toe dactylitis in patients with spondylarthropathy: assessment by Magnetic Resonance Imaging. J Rheumatol 1997 ; 24:926-30.
57. Wright V. Rheumatism and psoriasis. A re-evaluation. Am J Med 1959 ; 27:454-62.
58. Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 1990 ; 17:809-12.
59. Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997 ; 40:1868-72.
60. Gladman DD, Farewell VT, Wong K, Husted J. Mortality studies in psoriatic arthritis. Results from a single out-patient center. II. Prognostic indicators for death. Arthritis Rheum 1998 ; 41:1103-10.
61. Cuellar ML, Citera G, Espinoza LR. Treatment of psoriatic arthritis. Bailliéres's Clin Rheumatol 1994 ; 8:483-98.
62. Chaouat Y, Faurès B, Ginet C et al. Les thérapeutiques du rhumatisme psoriasique. Rev Rhum 1979 ; 46:561-8.
63. Hilliquin P, Grégoir C, Menkès CJ. Intérêt des bolus de méthylprednisolone dans les formes polyarticulaires du rhumatisme psoriasique. Rev Rhum 1992 ; 59:160-1.
64. Palit J, Capell HA, Carey J et al. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis. Br J Rheumatol 1990 ; 29:280-3.
65. Goupille P, Valat JP. Le traitement du rhumatisme psoriasis. Ann Med Interne 1994 ; 145:205-14.
66. Carette S, Calin A, McCafferty JP, Wallin BA. A double blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum 1989 ; 32:158-65.
67. Roux H, Schiano A, Maestracci D, Serratrice G. Notre expérience du traitement du rhumatisme psoriasis par la D-pénicillamine. Rev Rhum 1979 ; 46:631-3.
68. Bouvenot G. Réflexions sur les traitements médicamenteux du rhumatisme psoriasis. Sem Hôp Paris 1984 ; 60:2773-7.
69. Sayers ME, Mazanec DJ. Use of antimalarial drugs for the treatment of psoriatic arthritis. Am J Med 1992 ; 93:474-5.
70. Farr M, Kitas GD, Waterhouse L, Jubb R, Felix-Davies D, Bacon PA. Treatment of psoriatic arthritis with sulphasalazine: a one year open study. Clin Rheum 1988 ; 7:372-7.
71. Farr M, Kitas GD, Waterhouse L et al. Sulphasalazine in psoriatic arthritis: a double-bind placebo-controlled study. Br J Rheumatol 1990 ; 29:46-9.
72. Fraser SM, Hopkins R, Hunter JA, Neumann V, Capell HA, Bird HA. Sulphasalazine in the management of psoriatic arthritis. Br J Rheumatol 1993 ; 32:923-5.
73. Newman ED, Perruquet JL, Harrington TM. Sulfasalazine therapy in psoriatic arthritis: clinical and immunological response. J Rheumatol 1991 ; 18:1379-82.
74. Clegg DO, Reda DJ, Mejias E et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. Arthritis Rheum 1996 ; 39:2013-20.
75. Gupta AK, Grober JS, Hamilton TA et al. Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol 1995 ; 22:894-8.
76. Black RL, O'Brien WM, Van Scott EJ, Auerbach R, Eisen AZ, Bunim JJ. Methotrexate therapy in psoriatic arthritis. JAMA 1964 ; 189:743-7.
77. Wilkens RF, Williams HJ, Ward JR et al. Randomized, double-blind, placebo controlled trial of low dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984 ; 27:376-81.
78. Espinoza LR, Zakraoui L, Espinoza CG et al. Psoriatic arthritis: clinical response and side effects to methotrexate therapy. J Rheumatol 1992 ; 19:872-7.
79. Ranza R, Marchesoni A, Rosetti A, Tosi S, Gibelli E. Methotrexate in psoriatic polyarthritis. J Rheumatol 1993 ; 20:1804.
80. Abu-Shakra M, Gladman DD, Thorne JC, Long J, Gough J, Farewell VT. Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome. J Rheumatol 1995 ; 22:241-5.
81. Masson C, Chennebault JM, Leclech C. Is HIV infection contraindication to the use of methotrexate in psoriatic arthritis? J Rheumatol 1995 ; 22:2191.
82. Seideman P, Fjellner B, Johannesson A. Psoriatic arthritis treated with oral colchicine. J Rheumatol 1987 ; 14:777-9.
83. Le Quintrec JL, Menkès CJ, Amor B. Rhumatisme psoriasique grave, traitement par azathioprine. A propos de 11 cas. Rev Rhum 1990 ; 57:815-9.
84. Eibschutz B, Baird SM, Weisman MH et al. Oral 2-chlorodeoxyadenosine in psoriatic arthritis. A preliminary report. Arthritis Rheum 1995 ; 38:1604-9.
85. Schulze HJ, Mahrle G. Gamma interferon and psoriasis. Lancet 1986 ; 926-7.
86. Buskila D, Sukenik S, Holcberg G, Horowitz J. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia. J Rheumatol 1991 ; 18:611-2.
87. Eurly F, Mayaudon H, Bauduceau B et al. Prolactinémie sous protiréline (TRH) dans les spondylarthropathies. Tentative de traitemant de 4 cas d'arthrite réactionnelle et 2 cas de rhumatisme psoriasique par la bromocriptine. Ann Med Interne 1996 ; 147:15-19.
88. Klinhoff A, Gertner E, Chalmers A et al. Pilot study of etretinate in psoriatic arthritis. J Rheumatol 1991 ; 216:789-91.
89. Bussiére JL, Ristori JM. Les rétinoïdes sont-ils actifs dans le traitement du rhumatisme psoriasique? Presse Med 1988 ; 17:509-11.
90. Rampon S, Fraysse MP, Ristori JM, Sauvezie B, Bussiére JL, Souteyrand P. Traitement du rhumatisme psoriasique par un dérivé rétinoïde: l'étrétinate. Essai préliminaire ouvert sur 12 malades revus à 6 mois. Rev Rhum 1985 ; 52:127-31.
91. Huckins D, Felson DT, Holick M. Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study. Arthritis Rheum 1990 ; 33:1723-7.
92. Shapiro DL, Masci JR. Treatment of HIV associated psoriatic arthritis with oral gold. J Rheumatol 1996 ; 23:1818-20.